Effect of insulin and glucose on basal and cholecystokinin-stimulated exocrine pancreatic secretion in humans

Pancreas

Volumn 18, Issue 3, 1999, Pages 252-258

  Lam, W F ^a   Gielkens, H A J ^a   Coenraad, M ^a   Souverijn, J H M ^a   Lamers, C B H W ^a   Masclee, A A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cholecystokinin; Hyperglycemia; Hyperinsulinemia; Pancreaticobiliary secretion

Indexed keywords

BICARBONATE; BILIRUBIN; CHOLECYSTOKININ; GLUCOSE; INSULIN; PANCREAS ENZYME; TRYPSIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL MOTILITY; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPERINSULINEMIA; MALE; NORMAL HUMAN; PANCREAS FUNCTION; PANCREAS SECRETION; PRIORITY JOURNAL;

EID: 0345320406     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199904000-00006     Document Type: Article

References (42)

1. MacGregor IL, Deveney C, Way LW, Meyer JH. The effect of acute hyperglycemia on meal-stimulated gastric, biliary, and pancreatic secretion, and serum gastrin. Gastroenterology 1976;70: 197-202.
2. Øster-Jørgensen E, Qvist N, Pedersen SA, Rasmussen L, Hovendal CP. The influence of induced hyperglycaemia on the characteristics of intestinal motility and bile kinetics in healthy men. Scand J Gastroenterol 1992;27:285-8.
3. de Boer SY, Masclee AAM, Lam WF, Lamers CBHW. Effect of acute hyperglycemia on esophageal motility and lower esophageal sphincter pressure in humans. Gastroenterology 1992;103:775-80.
4. de Boer SY, Masclee AAM, Lam WF, Schipper J, Jansen JBMJ, Lamers CBHW. Hyperglycemia modulates gallbladder motility and small intestinal transit time in man. Dig Dis Sci 1993;38:2228-35.
5. de Boer SY, Masclee AAM, Lam WF, Schipper J, Jansen JBMJ, Lamers CBHW. Hyperglycemia reduces gallbladder emptying and plasma hormone secretion to modified sham feeding and regular feeding. Hepatology 1993;17:1022-7.
6. Lam WF, Masclee AAM, de Boer SY, Lamers CBHW. Hyperglycemia reduces gastric secretory and plasma pancreatic polypeptide responses to modified sham feeding in humans. Digestion 1993; 54:48-53.
7. Lam WF, Masclee AAM, Muller ESM, Lamers CBHW. Effect of hyperglycemia on gastric acid secretion and gastrin release induced by intravenous amino acids. Am J Clin Nutr 1995;61:1268-72.
8. Fraser R, Horowitz M, Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut 1991;32:475-8.
9. Lam WF, Masclee AAM, de Boer SY, Souverijn JHM, Lamers CBHW. Effect of acute hyperglycemia on basal and cholecystokinin stimulated exocrine pancreatic secretion in humans. Life Sci 1997;60:2183-90.
10. MacGregor IL, Gueller R, Watts HD, Meyer JH. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology 1976;70:190-6.
11. de Boer SY, Masclee AAM, Lam WF, et al. Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1994;37:75-81.
12. Øster-Jørgensen E, Pedersen SA, Larsen ML. The influence of induced hyperglycaemia on gastric emptying rate in healthy humans. Scand J Clin Lab Invest 1990;50:831-6.
13. Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990;33:675-80.
14. Niederau C, Sonnenberg A, Erckenbrecht J. Effects of intravenous infusion of amino acids, fat, or glucose on unstimulated pancreatic secretion in healthy humans. Dig Dis Sci 1985;30:445-55.
15. Eliasson B, Björnsson E, Urbanavicius V, et al. Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption. Diabetologia 1995;38:79-85.
16. Björnsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U, Abrahamsson H. Effects of insulin and beta-adrenergic blockade on the migrating motor complex in humans. Scand J Gastroenterol 1995;30:219-24.
17. Gielkens HAJ, Verkijk M, Frölich M, Lamers CBHW, Masclee AAM. Is the effect of acute hyperglycaemia on interdigestive antroduodenal motility and small-bowel transit mediated by insulin? Eur J Clin Invest 1997;27:703-10.
18. Williams JA, Sankaran H, Korc M, Goldfine ID. Receptors for cholecystokinin and insulin in isolated pancreatic acini: hormonal control of secretion and metabolism. Fed Proc 1981;40:2497-502.
19. Garry DJ, Garry MG, Williams JA, Mahoney WC, Sorenson RL. Effects of islets hormones on amylase secretion and localization of somatostatin binding sites. Am J Physiol 1989;256:G897-904.
20. Otsuki M, Williams JA. Direct modulation of pancreatic CCK receptors and enzyme secretion by insulin in isolated pancreatic acini from diabetic rats. Diabetes 1983;32:241-6.
21. Li Y, Owyang C. Pancreatic secretion evoked by cholecystokinin and non-cholecystokinin-dependent duodenal stimuli via vagal afferent fibres in the rat. J Physiol (Lond) 1996;494:773-82.
22. Hopman WPM, Rosenbusch G. Jansen JBMJ, de Jong AJL, Lamers CBHW. Gallbladder contraction: effects of fatty meals and cholecystokinin. Radiology 1985;157:37-9.
23. Schwartz TW. Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983;85:1411-25.
24. Ward WK, Halter JB, Beard JC, Porte D Jr. Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol 1984;246:E405-11.
25. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
26. Nijs HGT, Radder JK, Frölich M, Krans HMJ. In vivo relationship between insulin clearance and action in healthy subjects and IDDM patients. Diabetes 1990;39:333-9.
27. Beinfeld P. Alpha amylases. Methods Enzymol 1955:1:149-58.
28. Verduin PA, Punt JMHM, Kreutzer HH. Studies on the determination of lipase activity. Clin Chim Acta 1973;46:11-9.
29. Hummel BC. A modified spectrophotometric determination of chymotrypsin and thrombin. Can J Biochem 1955;37:1393-7.
30. Jendrassik L, Grof P. Vereinfachte photometrische Methoden zur Bestimmung des Blutbilirubins. Biochem Z 1938;297:81-9.
31. Hydén S. A turbidimetric method for the determination of higher polyethylene glycols in biological materials. Kungl Lantbrukshögsk Ann 1956;22:139-45.
32. Jebbink MC, Jansen JB, Mooy DM, Rovati LC, Lamers CB. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man. Regul Pept 1991;32:361-8.
33. Jansen JBMJ, Lamers CBHW. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta 1983;131:305-16.
34. Lamers CBHW, Diemel CM, Van Leer E, Van Leusen R, Peetoom JJ. Mechanism of elevated serum pancreatic polypeptide concentrations in chronic renal failure. J Clin Endocrinol Metab 1982; 55:922-6.
35. Berry SM, Fink AS. Exogenous insulin does not influence CCK- and meal-stimulated pancreatic secretion. Pancreas 1996;12:345-50.
36. Lee KY, Zhou L, Ren XS, Chang TM, Chey WY. An important role of endogenous insulin on exocrine pancreatic secretion in rats. Am J Physiol 1990;258:G268-74.
37. Greenberg GR, McCloy RF, Chadwick VS, Adrian TE, Baron JH, Bloom SR. Effect of bovine pancreatic polypeptide on basal pancreatic and biliary outputs in man. Dig Dis Sci 1979;24:11-4.
38. Greenberg GR, McCloy RF, Adrian TE, Chadwick VS, Baron JH, Bloom SR. Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet 1978;2:1280-2.
39. Li Y, Owyang C. Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J Clin Invest 1993;92:418-24.
40. Hirano T, Niijima A. Effects of 2-deoxy-D-glucose, glucose and insulin on efferent activity in gastric vagus nerve. Experientia 1980;36:1197-8.
41. Meier R, Hildebrand P, Thumshirn M, et al. Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans. Gastroenterology 1990;99:1757-62.
42. Tsuda K, Seino Y, Mori K, et al. Effect of truncal vagotomy on pancreatic polypeptide response after intravenous glucose administration. Regul Pept 1981;1:347-52.